A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty

A. Clavé; R. Gérard; J. Lacroix; C. Baynat; M. Danguy Des Déserts; F. Gatineau; D. Mottier

doi:10.1302/0301-620X.101B2.BJJ-2018-0898.R1

Journal articles

A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty

A. Clavé ¹ R. Gérard J. Lacroix C. Baynat M. Danguy Des Déserts F. Gatineau ² D. Mottier ^{3, 2}

1 CHU - BREST - Orthopédie - CHRU Brest - Service chirurgie orthopédique et traumatologique

2 CIC Brest

3 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Human health and pathology

Life Sciences [q-bio] / Human health and pathology / Surgery

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Complete list of metadata

https://hal.univ-brest.fr/hal-02059406
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Wednesday, March 6, 2019 - 3:50:48 PM
Last modification on : Thursday, March 31, 2022 - 11:00:02 AM

A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty

Identifiers

Collections

Citation

Export

Metrics

30

A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty

Identifiers

Collections

Citation

Export

Share

Metrics

30